100 related articles for article (PubMed ID: 3485042)
21. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
Aisenberg AC; Wilkes BM
Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
[TBL] [Abstract][Full Text] [Related]
22. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
23. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
Castella A; Davey FR; Kurec AS; Thompson NA
Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
[TBL] [Abstract][Full Text] [Related]
24. [The malignant lymphoproliferative diseases. Therapeutic progress and laboratory findings].
Hansen NE
Ugeskr Laeger; 2000 Jan; 162(1):26-7. PubMed ID: 10658485
[No Abstract] [Full Text] [Related]
25. Relationship between different cell surface markers in chronic lymphocytic leukemia.
Potomski J; Harłozińska A; Becker M; Noworolska A
Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
[TBL] [Abstract][Full Text] [Related]
26. Intramucosal lymphocytes of the gut: Lyt-2 and thy-1 phenotype of the granulated cells and evidence for the presence of both T cells and mast cell precursors.
Schrader JW; Scollay R; Battye F
J Immunol; 1983 Feb; 130(2):558-64. PubMed ID: 6129274
[TBL] [Abstract][Full Text] [Related]
27. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
28. T mu- and T gamma-cell subsets in normal and leukemic cattle.
Surovas V; Pieskus J; Tamosiunas V; Sadauskas P
Thymus; 1982 Jan; 4(1):31-43. PubMed ID: 6977208
[TBL] [Abstract][Full Text] [Related]
29. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
[TBL] [Abstract][Full Text] [Related]
30. [Differentiation of chronic lymphoid leukemia from the leukemic phase of non-Hodgkin's lymphoma using the M-rosette formation test].
Pecze K; Telek B; Kiss A; Rák K
Orv Hetil; 1985 Jul; 126(30):1835-6. PubMed ID: 3875068
[No Abstract] [Full Text] [Related]
31. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
Rak K; Pecze K; Kiss A; Telek B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
[TBL] [Abstract][Full Text] [Related]
32. Cell electrophoretic characterization of peripheral blood lymphocyte subpopulations enriched by rosette formation, from normal individuals and CLL patients.
Rychly J; Babusíková O; Koníková E; Anders O
Neoplasma; 1984; 31(1):57-64. PubMed ID: 6700796
[TBL] [Abstract][Full Text] [Related]
33. [The activity of growth-regulating substances isolated from the spleen and thymus of healthy cows and of those with hemoblastoses].
Ronichevskaia GM; Zlobina GA; Smirnova VV; Smirnov PN
Eksp Onkol; 1989; 11(4):63-6. PubMed ID: 2547575
[TBL] [Abstract][Full Text] [Related]
34. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. I. Acute lymphocytic leukaemia (ALL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):187-95. PubMed ID: 6326553
[TBL] [Abstract][Full Text] [Related]
35. The use of monoclonal antibodies in clinical haematology--the art of limitation.
Hokland P
Scand J Haematol; 1984 Jul; 33(1):5-8. PubMed ID: 6611582
[No Abstract] [Full Text] [Related]
36. AKR T-cell acute lymphoblastic leukemia: a model for human T-cell leukemia.
Bortin-M ; Truitt RL
Biomedicine; 1977 Oct; 26(5):309-11. PubMed ID: 303119
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
38. Chronic lymphocytic leukemia and related lymphoproliferative disorders.
Chew T; Amare M
J Kans Med Soc; 1980 Jan; 81(1):25-8. PubMed ID: 7351506
[No Abstract] [Full Text] [Related]
39. [Adenosine deaminase activity in hemoblastoses].
Krüger W; Müller G; Storch H; Kubel M; Richter V
Arch Geschwulstforsch; 1983; 53(1):53-9. PubMed ID: 6574729
[TBL] [Abstract][Full Text] [Related]
40. [Biological activity of various fractions of thymus extract].
Grinevich IuA; Nikol'skiĭ IS; Ovsienko VV; Chernenko OD
Fiziol Zh (1978); 1982; 28(6):741-5. PubMed ID: 6983459
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
